布地奈德 (Chinese Wikipedia)
Analysis of information sources in references of the Wikipedia article "布地奈德" in Chinese language version.
Last modified:
Ref.Un. Ref.Website
Global rank
Chinese rank
1st place
1st place
7,932nd place
7,224th place
3rd place
6th place
15th place
141st place
6th place
2nd place
low place
low place
5,833rd place
2,124th place
4th place
4th place
low place
low place
66th place
243rd place
low place
low place
2,191st place
2,031st place
137th place
188th place
7th place
21st place
884th place
1,371st place
1,280th place
814th place
low place
low place
279th place
2,458th place
low place
low place
low place
low place
archive.org (Global: 6th place; Chinese: 2nd place)
- Rudmik L, Schlosser RJ, Smith TL, Soler ZM. Impact of topical nasal steroid therapy on symptoms of nasal polyposis: a meta-analysis. The Laryngoscope. July 2012, 122 (7): 1431–7. PMID 22410935. S2CID 25637461. doi:10.1002/lary.23259.
- Lichtenstein GR, Hanauer SB, Sandborn WJ. Management of Crohn's Disease in Adults. Am J Gastroenterol. 2009, 104 (2): 465–83. PMID 19174807. S2CID 10176441. doi:10.1038/ajg.2008.168
. - Todd, G R G. Survey of adrenal crisis associated with inhaled corticosteroids in the United Kingdom. Archives of Disease in Childhood. 2002-12-01, 87 (6): 457–461. PMC 1755820 . PMID 12456538. doi:10.1136/adc.87.6.457.
bbc.co.uk (Global: 11th place; Chinese: 28th place)
- Roxby P. Covid: Asthma drug 'speeds up recovery at home'. BBC News. 2021-04-12 [2021-04-12]. （原始内容存档于2021-04-12）.
books.google.com (Global: 3rd place; Chinese: 6th place)
- Domeij B. Pharmaceutical patents in Europe. The Hague: Kluwer Law International. 2000: 278. ISBN 9789041113481. （原始内容存档于2015-12-08）.
- Hamley P. Small Molecule Medicinal Chemistry: Strategies and Technologies. John Wiley & Sons. 2015: 390. ISBN 9781118771693. （原始内容存档于2015-12-08）.
- Baily DG. Grapefruit and Other Fruit Juices Interactions with Medicines. Boullata JI, Armenti VT (编). Handbook of drug-nutrient interactions 2nd. New York, NY: Humana Press. 2010: 282 [2024-05-29]. ISBN 978-1-60327-362-6. （原始内容存档于2024-04-30）.
- Kizior RJ, Hodgson BB. Saunders Nursing Drug Handbook 2019 E-Book. Elsevier Health Sciences. 2018-02-21: 160 [2020-10-05]. ISBN 978-0-323-61257-9. （原始内容存档于2024-04-30）.
- Skidmore-Roth L, Richardson F. Mosby's Canadian Nursing Drug Reference - E-Book. Elsevier Health Sciences. 2020-07-09: 187 [2020-10-05]. ISBN 978-1-77172-084-7. （原始内容存档于2024-03-11）.
clincalc.com (Global: 5,833rd place; Chinese: 2,124th place)
- The Top 300 of 2021. ClinCalc. [2024-01-14]. （原始内容存档于2024-01-15）.
- Budesonide - Drug Usage Statistics. ClinCalc. [2024 -01-14]. （原始内容存档于2017-04-29）.
doi.org (Global: 2nd place; Chinese: 5th place)
- De Coster DA, Jones M. Tailoring of corticosteroids in COPD management. Current Respiratory Care Reports. 2014, 3 (3): 121–132. PMC 4113685 . PMID 25089228. doi:10.1007/s13665-014-0084-2.
- Christophi GP, Rengarajan A, Ciorba MA. Rectal budesonide and mesalamine formulations in active ulcerative proctosigmoiditis: efficacy, tolerance, and treatment approach. Clinical and Experimental Gastroenterology. 2016, 9: 125–30. PMC 4876845 . PMID 27274301. doi:10.2147/CEG.S80237 .
- Rudmik L, Schlosser RJ, Smith TL, Soler ZM. Impact of topical nasal steroid therapy on symptoms of nasal polyposis: a meta-analysis. The Laryngoscope. July 2012, 122 (7): 1431–7. PMID 22410935. S2CID 25637461. doi:10.1002/lary.23259.
- Silverman J, Otley A. Budesonide in the treatment of inflammatory bowel disease. Expert Review of Clinical Immunology. July 2011, 7 (4): 419–28. PMID 21790284. S2CID 32892611. doi:10.1586/eci.11.34.
- Pardi DS, Tremaine WJ, Carrasco-Labra A. American Gastroenterological Association Institute Technical Review on the Medical Management of Microscopic Colitis. Gastroenterology. January 2016, 150 (1): 247–274.e11. PMID 26584602. doi:10.1053/j.gastro.2015.11.006.
- Lichtenstein GR, Hanauer SB, Sandborn WJ. Management of Crohn's Disease in Adults. Am J Gastroenterol. 2009, 104 (2): 465–83. PMID 19174807. S2CID 10176441. doi:10.1038/ajg.2008.168 .
- Kuenzig ME, Rezaie A, Seow CH, Otley AR, Steinhart AH, Griffiths AM, et al. Budesonide for maintenance of remission in Crohn's disease.. Cochrane Database Syst Rev. 2014, 8 (8): CD002913. PMC 7133546 . PMID 25141071. doi:10.1002/14651858.CD002913.pub3.
- Habal FM, Huang VW. Review Article: A Decision-Making Algorithm For the Management of Pregnancy in the Inflammatory Bowel Disease Patient. Aliment Pharmacol Ther. 2012, 35 (5): 501–15. PMID 22221203. S2CID 34662981. doi:10.1111/j.1365-2036.2011.04967.x .
- Miehlke S, Guagnozzi D, Zabana Y, Tontini GE, Kanstrup Fiehn AM, Wildt S, Bohr J, Bonderup O, Bouma G, D'Amato M, Heiberg Engel PJ, Fernandez-Banares F, Macaigne G, Hjortswang H, Hultgren-Hörnquist E, Koulaouzidis A, Kupcinskas J, Landolfi S, Latella G, Lucendo A, Lyutakov I, Madisch A, Magro F, Marlicz W, Mihaly E, Munck LK, Ostvik AE, Patai ÁV, Penchev P, Skonieczna-Żydecka K, Verhaegh B, Münch A. European guidelines on microscopic colitis: United European Gastroenterology and European Microscopic Colitis Group statements and recommendations. United European Gastroenterology Journal. February 2021, 9 (1): 13–37. PMC 8259259 . PMID 33619914. doi:10.1177/2050640620951905.
- Stanaland BE. Once-daily budesonide aqueous nasal spray for allergic rhinitis: a review. Clinical Therapeutics. April 2004, 26 (4): 473–92. PMID 15189745. doi:10.1016/s0149-2918(04)90050-1.
- Rawla P, Sunkara T, Thandra KC, Gaduputi V. Efficacy and Safety of Budesonide in the Treatment of Eosinophilic Esophagitis: Updated Systematic Review and Meta-Analysis of Randomized and Non-Randomized Studies. Drugs in R&D. December 2018, 18 (4): 259–269. PMC 6277325 . PMID 30387081. doi:10.1007/s40268-018-0253-9.
- Todd, G R G. Survey of adrenal crisis associated with inhaled corticosteroids in the United Kingdom. Archives of Disease in Childhood. 2002-12-01, 87 (6): 457–461. PMC 1755820 . PMID 12456538. doi:10.1136/adc.87.6.457.
- Todd GR, Acerini CL, Buck JJ, Murphy NP, Ross-Russell R, Warner JT, McCance DR. Acute Adrenal Crisis in Asthmatics Treated With High-Dose Fluticasone Propionate. Eur Respir J. 2002, 19 (6): 1207–9. PMID 12108877. doi:10.1183/09031936.02.00274402 .
- Ajimura, Chanelle M.; Jagan, Nikhil; Morrow, Lee E.; Malesker, Mark A. Drug Interactions With Oral Inhaled Medications. Journal of Pharmacy Technology. December 2018, 34 (6): 273–280. ISSN 8755-1225. PMC 6231282 . PMID 34861014. doi:10.1177/8755122518788809 （英语）.
- Platform trial rules out treatments for COVID-19. NIHR Evidence (Plain English summary). 2022 -05-31 [2022-06-01]. doi:10.3310/nihrevidence_50873. （原始内容存档于2022-06-01）.
- Yu LM, Bafadhel M, Dorward J, Hayward G, Saville BR, Gbinigie O, Van Hecke O, Ogburn E, Evans PH, Thomas NP, Patel MG, Richards D, Berry N, Detry MA, Saunders C, Fitzgerald M, Harris V, Shanyinde M, de Lusignan S, Andersson MI, Barnes PJ, Russell RE, Nicolau DV, Ramakrishnan S, Hobbs FD, Butler CC. Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial. Lancet. September 2021, 398 (10303): 843–855. PMC 8354567 . PMID 34388395. doi:10.1016/S0140-6736(21)01744-X.
drugbank.com (Global: 7,932nd place; Chinese: 7,224th place)
go.drugbank.com
- Budesonide. go.drugbank.com. [2024-04-28]. （原始内容存档于2024-07-07） （英语）.
- Budesonide. go.drugbank.com. [2024-04-28]. （原始内容存档于2023-12-23） （英语）.
drugs.com (Global: 529th place; Chinese: 229th place)
- Budesonide. The American Society of Health-System Pharmacists. [2015-12-02]. （原始内容存档于2015-11-28）.
- Budesonide eent. The American Society of Health-System Pharmacists. [2015-12-02]. （原始内容存档于2015-12-08）.
- 英国药物信息
- Budesonide inhalation Uses, Side Effects & Warnings. Drugs.com. [2024-05-03]. （原始内容存档于2024-06-19） （英语）.
emedicinehealth.com (Global: low place; Chinese: low place)
- GENERIC NAME: BUDESONIDE - NASAL AEROSOL INHALER (byou-DESS-oh-nide). eMedicineHealth. （原始内容存档于2008-11-06）.
- What are the possible side effects of budesonide nasal (Childrens Rhinocort Allergy, Rhinocort Allergy, Rhinocort Aqua)?. eMedicineHealth. [2020-08-25]. （原始内容存档于2020-08-06）.
europa.eu (Global: 62nd place; Chinese: 150th place)
ema.europa.eu
- Jorveza EPAR. European Medicines Agency (EMA). 2018-09-17 [2023-03-03]. （原始内容存档于2023-03-04）.
- Kinpeygo EPAR. European Medicines Agency (EMA). 2022-05-17 [2023-03-03]. （原始内容存档于2023-03-04）.
- Budesonide: CMDh scientific conclusions and grounds for variation, amendments to the product information and timetable for the implementation - PSUSA/00000449/201604 (PDF). European Medicines Agency (EMA). 2017-03-10 [2017-05-19]. （原始内容存档 (PDF)于2017-09-08）.
- Kinpeygo: Pending EC decision. European Medicines Agency (EMA). 2022-05-20 [2022-05-20]. （原始内容存档于2022-05-20）. Text was copied from this source which is copyright European Medicines Agency. Reproduction is authorized provided the source is acknowledged.
ec.europa.eu
- Kinpeygo Product information. Union Register of medicinal products. [2023-03-03]. （原始内容存档于2023-03-04）.
fda.gov (Global: 470th place; Chinese: 386th place)
- First Generic Drug Approvals 2023. U.S. Food and Drug Administration (FDA). 2023-05-30 [2023-06-30]. （原始内容存档于2023-06-30）.
- FDA approves first drug to decrease urine protein in IgA nephropathy, a rare kidney disease. U.S. Food and Drug Administration (FDA). 2021-12-17 [2021-12-18]. （原始内容存档于2021-12-19）.
本条目含有公有领域來源内容。
ginasthma.org (Global: low place; Chinese: low place)
- Global Strategy for Asthma Management and Prevention, Global Initiative for Asthma (GiNA) 2011. Available at https://www.ginasthma.org 互联网档案馆的存檔，存档日期2013-10-14.
hdl.handle.net (Global: 66th place; Chinese: 243rd place)
- World Health Organization. World Health Organization model list of essential medicines: 21st list 2019. Geneva: World Health Organization. 2019. hdl:10665/325771 . WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.
hres.ca (Global: low place; Chinese: 7,116th place)
hpr-rps.hres.ca
- Regulatory Decision Summary - Uceris. Health Canada. 2014-10-23 [2022-06-04]. （原始内容存档于2022-06-05）.
justice.gov (Global: 884th place; Chinese: 1,371st place)
- Major Generic Drug Companies to Pay Over Quarter of a Billion Dollars to Resolve Price-Fixing Charges and Divest Key Drug at the Center of Their Conspiracy. DOJ. 2023-08-21 [2024-05-21]. （原始内容存档于2024-02-09）.
lexi.com (Global: low place; Chinese: low place)
online.lexi.com
- Budesonide (Oral Inhalation). Lexi-Drugs. UpToDate Lexidrug. UpToDate Inc. 2024-04-28 [2024-05-29]. （原始内容存档于2024-07-18）.
- Budesonide (Systemic). Lexi-Drugs. UpToDate Lexidrug. UpToDate Inc. 2024-04-28 [2024-05-29]. （原始内容存档于2024-07-18）.
- Budesonide (Oral Inhalation). Lexi-Drugs. UpToDate Lexidrug. UpToDate Inc. 2024 -04-28 [2024-05-29]. （原始内容存档于2024-07-18）.
- Budesonide (Topical). Lexi-Drugs. UpToDate Lexidrug. UpToDate Inc. 2024-04-28 [2024-05-29]. （原始内容存档于2024-07-18）.
- Budesonide (Nasal). Lexi-Drugs. UpToDate Lexidrug. UpToDate Inc. 2024-04-28 [2024-05-29]. （原始内容存档于2024-07-18）.
mayoclinic.org (Global: 2,191st place; Chinese: 2,031st place)
- Budesonide (Oral Route) Precautions - Mayo Clinic. www.mayoclinic.org. [2024-05-03]. （原始内容存档于2024-05-03）.
mhra.gov.uk (Global: low place; Chinese: low place)
cas.mhra.gov.uk
- COVID-19 Therapeutic Alert - Inhaled Budesonide for Adults (50 Years and Over) with COVID-19. Central Alerting System. 2021-04-12 [2021-04-16]. （原始内容存档于2021-04-12）.
- Withdrawal of the Recommendation for Consideration of Inhaled Budesonide as a Treatment Option for COVID-19. Central Alerting System. [2022-05-20]. （原始内容存档于2022-06-30）.
mohfw.gov.in (Global: low place; Chinese: low place)
- Clinical Management Protocol for Covid-19 (in Adults) (PDF). Ministry of Health and Family Welfare (India). 2021-05-24 [2021-07-10]. （原始内容存档 (PDF)于2021-12-05）.
newindianexpress.com (Global: 279th place; Chinese: 2,458th place)
- New guidelines prescribe inhaled steroid 'Budesonide', antiparasitic drug 'Ivermectin' for mild Covid cases. The New Indian Express. 2021-04-29 [021-07-11]. （原始内容存档于2021-11-06）.
nih.gov (Global: 5th place; Chinese: 3rd place)
ncbi.nlm.nih.gov
- De Coster DA, Jones M. Tailoring of corticosteroids in COPD management. Current Respiratory Care Reports. 2014, 3 (3): 121–132. PMC 4113685 . PMID 25089228. doi:10.1007/s13665-014-0084-2.
- Christophi GP, Rengarajan A, Ciorba MA. Rectal budesonide and mesalamine formulations in active ulcerative proctosigmoiditis: efficacy, tolerance, and treatment approach. Clinical and Experimental Gastroenterology. 2016, 9: 125–30. PMC 4876845 . PMID 27274301. doi:10.2147/CEG.S80237 .
- Rudmik L, Schlosser RJ, Smith TL, Soler ZM. Impact of topical nasal steroid therapy on symptoms of nasal polyposis: a meta-analysis. The Laryngoscope. July 2012, 122 (7): 1431–7. PMID 22410935. S2CID 25637461. doi:10.1002/lary.23259.
- Silverman J, Otley A. Budesonide in the treatment of inflammatory bowel disease. Expert Review of Clinical Immunology. July 2011, 7 (4): 419–28. PMID 21790284. S2CID 32892611. doi:10.1586/eci.11.34.
- Pardi DS, Tremaine WJ, Carrasco-Labra A. American Gastroenterological Association Institute Technical Review on the Medical Management of Microscopic Colitis. Gastroenterology. January 2016, 150 (1): 247–274.e11. PMID 26584602. doi:10.1053/j.gastro.2015.11.006.
- Lichtenstein GR, Hanauer SB, Sandborn WJ. Management of Crohn's Disease in Adults. Am J Gastroenterol. 2009, 104 (2): 465–83. PMID 19174807. S2CID 10176441. doi:10.1038/ajg.2008.168 .
- Kuenzig ME, Rezaie A, Seow CH, Otley AR, Steinhart AH, Griffiths AM, et al. Budesonide for maintenance of remission in Crohn's disease.. Cochrane Database Syst Rev. 2014, 8 (8): CD002913. PMC 7133546 . PMID 25141071. doi:10.1002/14651858.CD002913.pub3.
- Habal FM, Huang VW. Review Article: A Decision-Making Algorithm For the Management of Pregnancy in the Inflammatory Bowel Disease Patient. Aliment Pharmacol Ther. 2012, 35 (5): 501–15. PMID 22221203. S2CID 34662981. doi:10.1111/j.1365-2036.2011.04967.x .
- Miehlke S, Guagnozzi D, Zabana Y, Tontini GE, Kanstrup Fiehn AM, Wildt S, Bohr J, Bonderup O, Bouma G, D'Amato M, Heiberg Engel PJ, Fernandez-Banares F, Macaigne G, Hjortswang H, Hultgren-Hörnquist E, Koulaouzidis A, Kupcinskas J, Landolfi S, Latella G, Lucendo A, Lyutakov I, Madisch A, Magro F, Marlicz W, Mihaly E, Munck LK, Ostvik AE, Patai ÁV, Penchev P, Skonieczna-Żydecka K, Verhaegh B, Münch A. European guidelines on microscopic colitis: United European Gastroenterology and European Microscopic Colitis Group statements and recommendations. United European Gastroenterology Journal. February 2021, 9 (1): 13–37. PMC 8259259 . PMID 33619914. doi:10.1177/2050640620951905.
- Stanaland BE. Once-daily budesonide aqueous nasal spray for allergic rhinitis: a review. Clinical Therapeutics. April 2004, 26 (4): 473–92. PMID 15189745. doi:10.1016/s0149-2918(04)90050-1.
- Rawla P, Sunkara T, Thandra KC, Gaduputi V. Efficacy and Safety of Budesonide in the Treatment of Eosinophilic Esophagitis: Updated Systematic Review and Meta-Analysis of Randomized and Non-Randomized Studies. Drugs in R&D. December 2018, 18 (4): 259–269. PMC 6277325 . PMID 30387081. doi:10.1007/s40268-018-0253-9.
- Kalola, Urvashi K.; Ambati, Shashikanth, Budesonide, StatPearls (Treasure Island (FL): StatPearls Publishing), 2024 [2024-04-28], PMID 33085348, （原始内容存档于2024-03-30）
- Todd, G R G. Survey of adrenal crisis associated with inhaled corticosteroids in the United Kingdom. Archives of Disease in Childhood. 2002-12-01, 87 (6): 457–461. PMC 1755820 . PMID 12456538. doi:10.1136/adc.87.6.457.
- Todd GR, Acerini CL, Buck JJ, Murphy NP, Ross-Russell R, Warner JT, McCance DR. Acute Adrenal Crisis in Asthmatics Treated With High-Dose Fluticasone Propionate. Eur Respir J. 2002, 19 (6): 1207–9. PMID 12108877. doi:10.1183/09031936.02.00274402 .
- Ajimura, Chanelle M.; Jagan, Nikhil; Morrow, Lee E.; Malesker, Mark A. Drug Interactions With Oral Inhaled Medications. Journal of Pharmacy Technology. December 2018, 34 (6): 273–280. ISSN 8755-1225. PMC 6231282 . PMID 34861014. doi:10.1177/8755122518788809 （英语）.
- Yu LM, Bafadhel M, Dorward J, Hayward G, Saville BR, Gbinigie O, Van Hecke O, Ogburn E, Evans PH, Thomas NP, Patel MG, Richards D, Berry N, Detry MA, Saunders C, Fitzgerald M, Harris V, Shanyinde M, de Lusignan S, Andersson MI, Barnes PJ, Russell RE, Nicolau DV, Ramakrishnan S, Hobbs FD, Butler CC. Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial. Lancet. September 2021, 398 (10303): 843–855. PMC 8354567 . PMID 34388395. doi:10.1016/S0140-6736(21)01744-X.
dailymed.nlm.nih.gov
- Tarpeyo- budesonide capsule, delayed release. DailyMed. [2021-12-24]. （原始内容存档于2021-12-25）.
- Pulmicort Flexhaler- budesonide aerosol, powder. DailyMed. [2021-12-24]. （原始内容存档于2021-09-19）.
- Eohilia- budesonide suspension. DailyMed. 2024-02-09 [2024-02-26]. （原始内容存档于2024-02-26）.
nihr.ac.uk (Global: low place; Chinese: low place)
evidence.nihr.ac.uk
- Platform trial rules out treatments for COVID-19. NIHR Evidence (Plain English summary). 2022 -05-31 [2022-06-01]. doi:10.3310/nihrevidence_50873. （原始内容存档于2022-06-01）.
nytimes.com (Global: 7th place; Chinese: 21st place)
- Murphy H. Teva and Other Generic Drugmakers Inflated Prices Up to 1,000%, State Prosecutors Say. The New York Times. 2019-05-11 [2020-05-27]. （原始内容存档于2020-05-30）.
pharmaceutical-journal.com (Global: low place; Chinese: low place)
- Burns C. NICE removes budesonide from recommended COVID-19 treatments. The Pharmaceutical Journal. 2021-12-15 [2022-06-01]. （原始内容存档于2022-06-26）.
sciencedirect.com (Global: 137th place; Chinese: 188th place)
- Gavins, Felicity; Flower, Roderick J., Enna, S. J.; Bylund, David B. , 编, Budesonide, xPharm: The Comprehensive Pharmacology Reference (New York: Elsevier), 2008-01-01: 1–5 [2024-05-03], ISBN 978-0-08-055232-3, （原始内容存档于2022-07-22）
semanticscholar.org (Global: 15th place; Chinese: 141st place)
api.semanticscholar.org
- Rudmik L, Schlosser RJ, Smith TL, Soler ZM. Impact of topical nasal steroid therapy on symptoms of nasal polyposis: a meta-analysis. The Laryngoscope. July 2012, 122 (7): 1431–7. PMID 22410935. S2CID 25637461. doi:10.1002/lary.23259.
- Silverman J, Otley A. Budesonide in the treatment of inflammatory bowel disease. Expert Review of Clinical Immunology. July 2011, 7 (4): 419–28. PMID 21790284. S2CID 32892611. doi:10.1586/eci.11.34.
- Lichtenstein GR, Hanauer SB, Sandborn WJ. Management of Crohn's Disease in Adults. Am J Gastroenterol. 2009, 104 (2): 465–83. PMID 19174807. S2CID 10176441. doi:10.1038/ajg.2008.168 .
- Habal FM, Huang VW. Review Article: A Decision-Making Algorithm For the Management of Pregnancy in the Inflammatory Bowel Disease Patient. Aliment Pharmacol Ther. 2012, 35 (5): 501–15. PMID 22221203. S2CID 34662981. doi:10.1111/j.1365-2036.2011.04967.x .
thetimes.co.uk (Global: 1,280th place; Chinese: 814th place)
- Blakely R. Asthma drug Budesonide speeds up Covid recovery times
. The Times. 2021-04-12 [2021-04-13]. ISSN 0140-0460. （原始内容存档于202-11-06）.
web.archive.org (Global: 1st place; Chinese: 1st place)
- Regulatory Decision Summary - Uceris. Health Canada. 2014-10-23 [2022-06-04]. （原始内容存档于2022-06-05）.
- Tarpeyo- budesonide capsule, delayed release. DailyMed. [2021-12-24]. （原始内容存档于2021-12-25）.
- Pulmicort Flexhaler- budesonide aerosol, powder. DailyMed. [2021-12-24]. （原始内容存档于2021-09-19）.
- Eohilia- budesonide suspension. DailyMed. 2024-02-09 [2024-02-26]. （原始内容存档于2024-02-26）.
- Jorveza EPAR. European Medicines Agency (EMA). 2018-09-17 [2023-03-03]. （原始内容存档于2023-03-04）.
- Kinpeygo EPAR. European Medicines Agency (EMA). 2022-05-17 [2023-03-03]. （原始内容存档于2023-03-04）.
- Budesonide. The American Society of Health-System Pharmacists. [2015-12-02]. （原始内容存档于2015-11-28）.
- Budesonide eent. The American Society of Health-System Pharmacists. [2015-12-02]. （原始内容存档于2015-12-08）.
- Domeij B. Pharmaceutical patents in Europe. The Hague: Kluwer Law International. 2000: 278. ISBN 9789041113481. （原始内容存档于2015-12-08）.
- Hamley P. Small Molecule Medicinal Chemistry: Strategies and Technologies. John Wiley & Sons. 2015: 390. ISBN 9781118771693. （原始内容存档于2015-12-08）.
- First Generic Drug Approvals 2023. U.S. Food and Drug Administration (FDA). 2023-05-30 [2023-06-30]. （原始内容存档于2023-06-30）.
- The Top 300 of 2021. ClinCalc. [2024-01-14]. （原始内容存档于2024-01-15）.
- Budesonide - Drug Usage Statistics. ClinCalc. [2024 -01-14]. （原始内容存档于2017-04-29）.
- Global Strategy for Asthma Management and Prevention, Global Initiative for Asthma (GiNA) 2011. Available at https://www.ginasthma.org 互联网档案馆的存檔，存档日期2013-10-14.
- FDA approves first drug to decrease urine protein in IgA nephropathy, a rare kidney disease. U.S. Food and Drug Administration (FDA). 2021-12-17 [2021-12-18]. （原始内容存档于2021-12-19）. 本条目含有公有领域來源内容。
- GENERIC NAME: BUDESONIDE - NASAL AEROSOL INHALER (byou-DESS-oh-nide). eMedicineHealth. （原始内容存档于2008-11-06）.
- What are the possible side effects of budesonide nasal (Childrens Rhinocort Allergy, Rhinocort Allergy, Rhinocort Aqua)?. eMedicineHealth. [2020-08-25]. （原始内容存档于2020-08-06）.
- Budesonide: CMDh scientific conclusions and grounds for variation, amendments to the product information and timetable for the implementation - PSUSA/00000449/201604 (PDF). European Medicines Agency (EMA). 2017-03-10 [2017-05-19]. （原始内容存档 (PDF)于2017-09-08）.
- Kalola, Urvashi K.; Ambati, Shashikanth, Budesonide, StatPearls (Treasure Island (FL): StatPearls Publishing), 2024 [2024-04-28], PMID 33085348, （原始内容存档于2024-03-30）
- Budesonide (Oral Route) Precautions - Mayo Clinic. www.mayoclinic.org. [2024-05-03]. （原始内容存档于2024-05-03）.
- Budesonide inhalation Uses, Side Effects & Warnings. Drugs.com. [2024-05-03]. （原始内容存档于2024-06-19） （英语）.
- Budesonide (Oral Inhalation). Lexi-Drugs. UpToDate Lexidrug. UpToDate Inc. 2024-04-28 [2024-05-29]. （原始内容存档于2024-07-18）.
- Baily DG. Grapefruit and Other Fruit Juices Interactions with Medicines. Boullata JI, Armenti VT (编). Handbook of drug-nutrient interactions 2nd. New York, NY: Humana Press. 2010: 282 [2024-05-29]. ISBN 978-1-60327-362-6. （原始内容存档于2024-04-30）.
- Kizior RJ, Hodgson BB. Saunders Nursing Drug Handbook 2019 E-Book. Elsevier Health Sciences. 2018-02-21: 160 [2020-10-05]. ISBN 978-0-323-61257-9. （原始内容存档于2024-04-30）.
- Skidmore-Roth L, Richardson F. Mosby's Canadian Nursing Drug Reference - E-Book. Elsevier Health Sciences. 2020-07-09: 187 [2020-10-05]. ISBN 978-1-77172-084-7. （原始内容存档于2024-03-11）.
- Gavins, Felicity; Flower, Roderick J., Enna, S. J.; Bylund, David B. , 编, Budesonide, xPharm: The Comprehensive Pharmacology Reference (New York: Elsevier), 2008-01-01: 1–5 [2024-05-03], ISBN 978-0-08-055232-3, （原始内容存档于2022-07-22）
- Budesonide (Systemic). Lexi-Drugs. UpToDate Lexidrug. UpToDate Inc. 2024-04-28 [2024-05-29]. （原始内容存档于2024-07-18）.
- Budesonide. go.drugbank.com. [2024-04-28]. （原始内容存档于2024-07-07） （英语）.
- Budesonide (Oral Inhalation). Lexi-Drugs. UpToDate Lexidrug. UpToDate Inc. 2024 -04-28 [2024-05-29]. （原始内容存档于2024-07-18）.
- Budesonide (Topical). Lexi-Drugs. UpToDate Lexidrug. UpToDate Inc. 2024-04-28 [2024-05-29]. （原始内容存档于2024-07-18）.
- Budesonide. go.drugbank.com. [2024-04-28]. （原始内容存档于2023-12-23） （英语）.
- Budesonide (Nasal). Lexi-Drugs. UpToDate Lexidrug. UpToDate Inc. 2024-04-28 [2024-05-29]. （原始内容存档于2024-07-18）.
- Murphy H. Teva and Other Generic Drugmakers Inflated Prices Up to 1,000%, State Prosecutors Say. The New York Times. 2019-05-11 [2020-05-27]. （原始内容存档于2020-05-30）.
- Major Generic Drug Companies to Pay Over Quarter of a Billion Dollars to Resolve Price-Fixing Charges and Divest Key Drug at the Center of Their Conspiracy. DOJ. 2023-08-21 [2024-05-21]. （原始内容存档于2024-02-09）.
- Kinpeygo: Pending EC decision. European Medicines Agency (EMA). 2022-05-20 [2022-05-20]. （原始内容存档于2022-05-20）. Text was copied from this source which is copyright European Medicines Agency. Reproduction is authorized provided the source is acknowledged.
- Kinpeygo Product information. Union Register of medicinal products. [2023-03-03]. （原始内容存档于2023-03-04）.
- COVID-19 Therapeutic Alert - Inhaled Budesonide for Adults (50 Years and Over) with COVID-19. Central Alerting System. 2021-04-12 [2021-04-16]. （原始内容存档于2021-04-12）.
- Roxby P. Covid: Asthma drug 'speeds up recovery at home'. BBC News. 2021-04-12 [2021-04-12]. （原始内容存档于2021-04-12）.
- Blakely R. Asthma drug Budesonide speeds up Covid recovery times. The Times. 2021-04-12 [2021-04-13]. ISSN 0140-0460. （原始内容存档于202-11-06）.
- Platform trial rules out treatments for COVID-19. NIHR Evidence (Plain English summary). 2022 -05-31 [2022-06-01]. doi:10.3310/nihrevidence_50873. （原始内容存档于2022-06-01）.
- New guidelines prescribe inhaled steroid 'Budesonide', antiparasitic drug 'Ivermectin' for mild Covid cases. The New Indian Express. 2021-04-29 [021-07-11]. （原始内容存档于2021-11-06）.
- Clinical Management Protocol for Covid-19 (in Adults) (PDF). Ministry of Health and Family Welfare (India). 2021-05-24 [2021-07-10]. （原始内容存档 (PDF)于2021-12-05）.
- Burns C. NICE removes budesonide from recommended COVID-19 treatments. The Pharmaceutical Journal. 2021-12-15 [2022-06-01]. （原始内容存档于2022-06-26）.
- Withdrawal of the Recommendation for Consideration of Inhaled Budesonide as a Treatment Option for COVID-19. Central Alerting System. [2022-05-20]. （原始内容存档于2022-06-30）.
worldcat.org (Global: 4th place; Chinese: 4th place)
- Ajimura, Chanelle M.; Jagan, Nikhil; Morrow, Lee E.; Malesker, Mark A. Drug Interactions With Oral Inhaled Medications. Journal of Pharmacy Technology. December 2018, 34 (6): 273–280. ISSN 8755-1225. PMC 6231282 . PMID 34861014. doi:10.1177/8755122518788809 （英语）.
- Blakely R. Asthma drug Budesonide speeds up Covid recovery times. The Times. 2021-04-12 [2021-04-13]. ISSN 0140-0460. （原始内容存档于202-11-06）.